In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-14 of 14 for your search:
Drug:  yttrium Y 90 ibritumomab tiuxetan
Find trials that include:  Any drugs shown
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02721, AMC-037, U01CA070019, CDR0000310158, NCT00064246

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: NCI, Other
Protocol IDs: 98153, P30CA033572, P01CA030206, CHNMC-98153, CDR0000574716, NCT00562978

3.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: 02-090, MSKCC-02090, NCT00058422

4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000304498, CALGB-50201, SWOG-C50201, ECOG-C50201, NCT00062114

5.

Phase: Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000329864, U10CA032102, S0313, SWOG-S0313, NCT00070018

6.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 1726.00, NCI-2010-01381, FHCRC-1726.00, 5787, NCT00119392

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000334470, ECOG-E1499, E1499, NCT00070447

8.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: BMT134, 80109, NCT00186589

9.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000546732, P30CA015083, MC048A, 449-05, NCI-2009-01399, 021-03-ZEV, 106-P148, MAYO-MC048A, MAYO-IRB-449-05, NCT00477815

10.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: LCCC 0525, CDR0000550130, UNC-LCCC-0525, NCT00334438

11.

Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 17
Sponsor: NCI, Other
Protocol IDs: NU 99H11, IDEC-NU99H11, NCT00058292

12.

Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: NCI-2012-03156, J0004, JHOC-J0004, NCI-970, 970, NCT00017381

13.

Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 04-009, MSKCC-04009, NCT00082836

14.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 100
Sponsor: NCI, Other
Protocol IDs: JHOC-J0636, CDR0000522705, NCT00416312
New Search